Replies to post #730026 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

One has Tim Cloughesy from ucla talking on the gbm AGILE program ongoing.

The Agile trial was designed to bring various possible treatments for GBM into the same trial and try to see how they played out against each other with various biomarkers.

NWBO passed on it for some reason.

[Hopeforthefuture3]

Another presentation on Musellafoundation by Mimivax a spinoff from Roswell Park in a phase 2b trial with 63 gbm patients had 27% survival at 5 years. Vaccine sounds a bit similar to nwbo's but not personalized but at this point good results
Ceo of company presenting. Seems like LP or Bosch should get on the show and talk on the nwbo phase3 results.
Survaxm is vaccine, for methylated median OS at 41 months